… have important effects in hormone-naïve rather HRPC patients. In this report, we compared
the effects carnertinib in a wide panel of prostate cancer cells in vitro and in three models of …

… efficacy in prostate cancer xenograft models—including … are beneficial in prostate cancer
xenograft models; berberine … bearing PTEN-null castrate-resistant prostate cancer were fed a …

… found that a BRCA-2 gene deletion occurred frequently in castrate resistant prostate cancer
… Antitumor effects of carnertinib in castration resistant prostate cancer models: A Comparative …

… progress to castration resistant prostate cancer (CRPC), … effective against prostate cancer
cells and animal models compared … C, comparison of the activation and expression of the ErbB …

… Whereas the carnertinib efficacy may have therapeutical significance in HER2 … al: Antitumor
effects of carnertinib in castration resistant prostate cancer models: a comparative study with …

… Castration-resistant prostate cancer (CRPC) is associated with poor prognosis and …
Antitumor effects of carnertinib in castration resistant prostate cancer models: A Comparative …

… Next, we investigated the effect of WCE on another CRPC model (Figure 7A). After LNCaP
… WCE is comparable to castration according to our in vivo and in vitro growth assays (Figures …

… above, we treated castration-resistant prostate cancer cells 22RV1 with … Therefore, we
mainly tested the anti-tumor effects of four … The results are comparable with those in Fig 6L. The …

… of human cancer cells, we used the prostate cancer cell … antitumor effect of the combined
therapy with VSV and sunitinib. In the presence of continued treatments with sunitinib, tumor …

… prostate gland. Almost 30 years ago, mean serum testosterone levels were reported to be
higher in AA men in comparison … occur, leading to castration-resistant prostate cancer (CRPC) […